Toggle Dropdown
Groups
Announcements
Projects
Ideas
Welcome guest
Log in
Practice
My Requests
All Requests
Drill Partners
Digital games
Projects
Goals
Loading
Loading...
0
0
BioNTech starts human trials on a vaccine for malaria - BusinessLIVE
12/23/22 at 9:13am
Organization
Bloomberg
Author
Naomi Kresge
26 words
0
Comments
The company’s planned vaccine production site in Kigali, Rwanda will help produce the malaria shot
Infectious Diseases
Public Health
Public Safety
Health
Medical Procedures
BioNTech
vaccine production site
malaria shot
Rwanda
Kigali
You are the first to view
https://www.bloomberg.com/news/articles/2022-12-23/biontech-starts-malaria-trial-in-new-test-for-mrna-vaccines
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...